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Abstract
Background: Skeletal muscle growth and development from embryo to adult consists of a series of carefully
regulated changes in gene expression. Understanding these developmental changes in agriculturally important
species is essential to the production of high quality meat products. For example, consumer demand for lean,
inexpensive meat products has driven the turkey industry to unprecedented production through intensive genetic
selection. However, achievements of increased body weight and muscle mass have been countered by an
increased incidence of myopathies and meat quality defects. In a previous study, we developed and validated a
turkey skeletal muscle-specific microarray as a tool for functional genomics studies. The goals of the current study
were to utilize this microarray to elucidate functional pathways of genes responsible for key events in turkey
skeletal muscle development and to compare differences in gene expression between two genetic lines of turkeys.
To achieve these goals, skeletal muscle samples were collected at three critical stages in muscle development: 18d
embryo (hyperplasia), 1d post-hatch (shift from myoblast-mediated growth to satellite cell-modulated growth by
hypertrophy), and 16wk (market age) from two genetic lines: a randombred control line (RBC2) maintained without
selection pressure, and a line (F) selected from the RBC2 line for increased 16wk body weight. Array hybridizations
were performed in two experiments: Experiment 1 directly compared the developmental stages within genetic
line, while Experiment 2 directly compared the two lines within each developmental stage.
Results: A total of 3474 genes were differentially expressed (false discovery rate; FDR < 0.001) by overall effect of
development, while 16 genes were differentially expressed (FDR < 0.10) by overall effect of genetic line. Ingenuity
Pathways Analysis was used to group annotated genes into networks, functions, and canonical pathways. The
expression of 28 genes involved in extracellular matrix regulation, cell death/apoptosis, and calcium signaling/
muscle function, as well as genes with miscellaneous function was confirmed by qPCR.
Conclusions: The current study identified gene pathways and uncovered novel genes important in turkey muscle
growth and development. Future experiments will focus further on several of these candidate genes and the
expression and mechanism of action of their protein products.
Background
Hyperplasia and hypertrophy are key processes in myo-
genesis in the domestic turkey. It is well established that
the number of muscle fibers is determined embryoni-
cally [1], as myoblasts, originating as somites, migrate to
t h ea p p r o p r i a t es i t eo fm u s c l ef o r m a t i o n ,t h e n
proliferate during the process of hyperplasia. These
myoblasts then withdraw from the cell cycle, fuse to
form multi-nucleated myotubes, and differentiate with
commencement of muscle-specific protein expression.
After the actual number of muscle fibers is determined
during hyperplasia, skeletal muscle stem cells, satellite
cells located beneath the basal lamina of the muscle
fibers, are activated and fuse with muscle fibers to con-
tribute their nuclei, resulting in a further increase in
DNA that directly leads to an increase in protein
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any medium, provided the original work is properly cited.synthesis. This post-hatch increase in muscle fiber size
(hypertrophy) is responsible for the majority of overall
muscle mass accretion [2,3].
All of these events are precisely temporally and spa-
tially regulated by transcription factors, growth factors,
and interactions with the extracellular matrix (ECM).
The transcription factors Pax3 and Pax7 are responsible
early on for determination of cells entering the myo-
genic program as well as the activation and survival of
satellite cells [4,5]. Myogenic regulatory factors (MRFs),
including the four basic helix-loop-helix transcription
factors Myf5, myogenin, MRF4, and MyoD, are pivotal
in regulating genes involved with commitment of prolif-
erating somatic cells to the myogenic lineage and subse-
quent differentiation [6]. Myocyte enhancer factors
(MEFs) comprise another group of transcription factors
that work in conjunction with the MRFs to ensure
appropriate expression of muscle-specific proteins dur-
ing differentiation. Binding sites for MEF2s have been
discovered in the promoters of many crucial skeletal
muscle structural genes [7]. These groups of transcrip-
tion factors also regulate each other [6,7]. Furthermore,
the activation, proliferation, and differentiation of satel-
lite cells are regulated by various growth factors, includ-
ing insulin-like growth factors (IGF), fibroblast growth
factor 2 (FGF2), platelet-derived growth factors (PDGF),
hepatocyte growth factors, (HGF), epidermal growth fac-
tors (EGF), and transforming growth factor-b (TGF-b)
[8]. Satellite cell response to the growth factors IGF and
FGF2 is different between fast-growing and slow-grow-
ing breeds of domestic turkeys [9].
A genetic model has been developed and maintained
to study the effects of growth selection in turkeys. This
model consists of two lines: a randomly bred control
line of turkeys (RBC2), maintained without selection
pressure and representing a commercial turkey from
1967 [10], and a unique line genetically derived from
the RBC2 birds and selected for over 40 generations
solely for 16-wk body weight (F) [11]. The F line turkeys
gain body weight faster and yield significantly heavier
breast muscles than the RBC2 birds [12]. In addition,
satellite cells from F turkeys have higher proliferation
and differentiation rates than those from RBC2 turkeys
[13]. Growth comparisons between these two lines are
not confounded by selection for other characteristics
such as disease resistance, reproductive efficiency, or
behavioral traits, as are commercial turkeys.
Many gene expression differences between these two
lines have been identified in vitro using isolated satellite
cells. The MRFs MyoD and myogenin are differentially
expressed between F and RBC2 lines in embryonic pec-
toralis major muscle and cultured satellite cells [14]. In
addition, proteoglycans in the extracellular matrix that
interact with growth factors important for proliferation
and differentiation of satellite cells exhibit differential
expression between the two lines [15,16]. These cell cul-
ture studies have been pivotal for understanding how
satellite cells contribute to muscle growth.
To build on this work, we developed a microarray
approach that enabled the simultaneous analysis of skeletal
muscle gene transcripts at specific time points in vivo.P r e -
viously, our group created and characterized a skeletal
muscle-specific microarray, the Turkey Skeletal Muscle
Long Oligonucleotide (TSKMLO) array, with the purpose
of screening the skeletal muscle transcriptome for candi-
date genes critical in growth, proliferation, differentiation,
and overall development [17,18]. Briefly, cDNA libraries
were constructed and sequenced using turkey Pectoralis
major muscle collected at three stages crucial to develop-
ment. From these libraries, oligonucleotides representing
5257 putative transcripts as well as oligonucleotides repre-
senting unique sequences to control for nonspecific hybri-
dization and template quality were designed and spotted,
resulting in the 6K skeletal muscle-specific oligonucleotide
microarray. Assessment of this platform using dye-swap
experiments, evaluation of control probe signals, and
qPCR validation of results established this array as a valid
and valuable tool for functional genomics studies. The
aims of the current study were to utilize this microarray to
elucidate functional pathways of genes responsible for key
events in turkey skeletal muscle development and to iden-
tify differences in temporal gene expression between two
genetic lines.
Methods
Animals and Tissue Collection
Animals used in this study were domestic turkeys main-
tained at the Poultry Research Center at The Ohio Agri-
cultural Research and Development Center located in
Wooster, OH under AGACUC protocol #04-AG007.
These turkeys were from two genetic lines: RBC2, a ran-
domly bred control line representative of a 1967 com-
mercial turkey [10,19], and F, a subline genetically
selected from the RBC2 line for increased 16wk body
weight [11]. The birds were euthanized immediately
prior to tissue harvest at one of three developmental
stages: 18 d embryo (18de; hyperplasia), 1 d post hatch
(1d; shift from myoblast-mediated growth to satellite
cell modulated growth by hypertrophy), and 16 wk old
birds (16wk; approximate age of commercial slaughter).
Pectoralis major muscle was excised [17], snap frozen in
liquid nitrogen, and stored at -80°C until shipment on
dry ice to Michigan State University (MSU), where sam-
ples were stored at -80°C until RNA extraction.
RNA Extraction
Total RNA was isolated from skeletal muscle tissue
using TRIReagent (Molecular Research Center, Inc.,
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samples were treated with DNA-free™ DNase (Ambion,
Inc., Austin, TX) to remove any contaminating genomic
DNA. Sample integrity was confirmed using an Agilent
2100 Bioanalyzer (Santa Clara, CA) that determined
RNA Integrity Number (RIN). All samples used for
microarray analysis had an RIN > 8.0.
Microarray Experimental Design
The TSKLMO array was designed and created based on
sequences from cDNA libraries constructed at crucial
stages in muscle development [18]. Description of this
platform can be found on the National Center for Bio-
technology Information (NCBI) Gene Expression Omni-
bus (GEO) database [GEO: GPL9788]. Experiment 1
(Additional File 1, Figure S1a) was designed to directly
compare the three developmental stages, 18de vs. 1d or
1d vs. 16wk, for each of the genetic lines. Experiment 2
(Additional File 1, Figure S1b) was designed to directly
compare the two genetic lines, F vs. RBC2, at each of
the developmental stages. Each Experiment contained
10 arrays per comparison; therefore, Experiment 1 con-
tained 40 arrays, and Experiment 2 contained 30 arrays.
Birds were randomly assigned to array, and hybridiza-
tions were performed in random order.
RNA Amplification and Microarray Hybridization
Total RNA for microarray analysis was amplified and
dye-coupled in preparation for hybridization using the
Amino Allyl MessageAmp™ II aRNA Amplification Kit
(Ambion, Inc.) per manufacturer instructions. All micro-
array preparation and hybridization procedures were
performed as previously described [17]. Briefly, all
microarrays were UV-crosslinked and pre-hybridized
prior to hybridization. Fragmented, Cy3-coupled aRNA
was mixed with its Cy5-coupled partner, and the mix-
tures were hybridized to oligonucleotide microarrays for
1 8hi naG e n e T a cH y b r i d i z a t i o nS t a t i o n( G e n o m i c
Solutions, Ann Arbor, MI). Arrays were then rinsed,
dried by centrifugation, and immediately scanned with a
GenePix 4000B scanner (Molecular Devices, Sunnyvale,
CA). Image analysis was performed using GenePix Pro
6.0 software, and spot intensities were exported as GPR
files for statistical analysis. Fluorescence intensity data
were not background-corrected in accordance with
recent recommendations [20,21] but were normalized
for dye intensity bias using the LOESS procedure of the
normalizeWithinArray function of the Bioconductor R
software LIMMA [22].
Statistical Analysis
The two sets of experiments were analyzed separately.
For the first experiment, in which 1d was directly com-
pared against the other two stages within arrays and
within lines, all microarray data were expressed as log2
ratios of each stage with 1d for each array. These log2
ratios were analyzed using a linear mixed model based
on an overall intercept, the effect of dye assignment for
samples deriving from stage 1d, effects of the other two
stages specified as numerator terms in the log2 ratios,
effect of line, and the random effects of the animal
assigned to stage 1d and its interaction with the other
two stages to serve as the experimental error term for
stage as each oligonucleotide was spotted twice on an
array. For this experiment, the comparisons of interest
included all stages against each other within each of the
two lines, as well as overall differences between the
three stages.
For the second experiment, in which lines were com-
pared directly against each other within arrays and
within stages, all data were expressed as log2 ratios of F
over RBC2 for each array. These log2 ratios were ana-
lyzed using a linear mixed model based on an overall
intercept, the dye assignment for samples deriving from
line RBC2, stage effects, the effect of line, and the ran-
dom effect of the animal derived from the RBC2 line.
The random effect could have been also arbitrarily cho-
sen as the animal derived from the F line, but, in either
case, this specification ensured that replication was
based on the number of animals and not on the number
of spots per gene per array. In this experiment, the com-
parisons of interest were overall line differences and line
differences within each stage. SAS PROC MIXED was
used for both analyses given the linear mixed model
specifications for both experiments [23]. Statistical sig-
nificance was based on the estimated false discovery
rates (FDR) [24].
Raw Cy5 intensities, raw Cy3 intensities, LOESS-nor-
malized log2 Cy5:Cy3 ratios, and LOESS-normalized log2
average intensities (A), as well as original GPR files for all
arrays, were submitted to the National Center for Biotech-
nology Information (NCBI)’s Gene Expression Omnibus
(GEO) [GSE19585]. Control probes were also evaluated
for both Experiments 1 and 2. Results examining the fluor-
escence intensities of probes designed to contain an
increasing number of mismatched bases as well as
scrambled sequence oligos that served as negative controls
indicated that hybridization was specific in these experi-
ments. These data have been previously presented [17].
Gene annotation and functional analysis
After statistical analysis, genes were sorted by FDR, and
the top 200 genes differentially expressed by overall
effect of development (Experiment 1) and all genes dif-
ferentially expressed by overall effect of genetic line
(Experiment 2) were investigated by subjecting oligonu-
cleotide sequences to an NCBI BLAST search and
choosing best matches for accession number and
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and down-regulated genes in Experiment 1 and all dif-
ferentially expressed genes in Experiment 2 in each
comparison: F 18de:1d, F 1d:16wk, RBC2 18de:1d, and
RBC2 1d:16wk were annotated in the same manner.
These lists were then probed for patterns in expression
using the Ingenuity PathwaysA n a l y s i ss o f t w a r e( I P A ;
Redwood City, CA).
Quantitative real-time PCR confirmation
Twenty-eight genes were chosen by function of interest
and high differential expression by microarray analysis
for confirmation of those results by quantitative real-
time PCR (qPCR). Primers (Table 1) were designed
using Primer Express 3.0 software (Applied Biosystems,
Foster City, CA) and synthesized by Operon Inc.
(Huntsville, AL). Sample RNAs (2 μg) were reverse tran-
scribed to cDNA using Superscript III (Invitrogen,
Carlsbad, CA) and quantified with a Nanodrop ND-
1000 spectrophotometer (Thermo Fisher Scientific, Inc.,
Wilmington, DE). Reactions were run using 10 ng
cDNA, 300 nM primer mix, and POWR SYBR Green
Master Mix in a 7700 thermocycler system (Applied
Biosystems). Data were analyzed by the 2
-ΔΔCt method
[25] using hypoxanthine phosphoribosyltransferase
(HPRT) as a reference gene and the RBC2, 18de stage as
the calibrator; i.e., RBC2, 18de expression is set to “1.0,”
and all other results are shown as a fold change relative
to this control. Statistical analysis was performed using
a mixed model and Tukey-Kramer test (SAS, Cary, NC).
Results
Differential expression of skeletal muscle genes
In Experiment 1, a total of 3474 genes were differentially
expressed between at least two developmental stages
across both genetic lines (FDR < 0.001; Table 2). Of
these, 2544 genes were significantly affected for the
RBC2 birds, whereas 2248 were significantly affected for
the F birds (Table 2). A greater number of genes were
up-regulated in the earlier developmental stage of direct
comparisons (i.e., 18de in the 18de:1d comparison or 1d
in the 1d:16wk comparison) as compared to those that
were down-regulated, and this observation was more
p r o n o u n c e di nt h eR B C 2l i n et h a nt h eFl i n e .T h et o p
30 down- and up-regulated genes in each comparison
are listed in Additional File 2, Table S1. A much smaller
number of genes were significantly affected by genetic
line in Experiment 2 (Table 2). Only 16 genes were dif-
ferentially expressed by overall effect of line at an FDR
< 0.10. When considering the effect of line within each
developmental stage rather than overall effect across
stages, the highest number of genes (63) were affected
at the 18de developmental stage (RBC2:F; 39 up-regu-
lated, 24 down-regulated). At 1d post-hatch, 20 genes
were differentially expressed (5 up, 10 down), and at
16wk, 8 genes were differentially expressed (4 up, 4
down). The annotations for these genes are detailed in
Additional File 3, Table S2.
Functional and pathway analysis
After differentially expressed oligos on the TSKMLO
array were annotated, lists of accession numbers were
subjected to IPA analysis, and Networks (which involve
regulatory relationships), Functions (which involve bio-
logical and disease processes), and Canonical Pathways
(which involve well-characterized cell signaling and
metabolic pathways) were considered when investigating
functional groups of genes differentially expressed in
turkey skeletal muscle during development. These
results for Experiment 1 are shown separately for the
R B C 2l i n ea n df o rt h eFl i n e( T a b l e3 ) .E x p e r i m e n t2
results are shown in Table 4; developmental stages were
grouped together because of the small number of differ-
entially expressed genes.
qPCR confirmation of differentially expressed genes
Genes in the categories of ECM function, cell death, and
skeletal muscle development and function, along with
several genes with miscellaneous functions, were
selected for qPCR confirmation of microarray results. In
addition, genes common to both Experiments 1 and 2
were selected for confirmation.
Figure 1 shows results for versican (1A), glypican-1
(1B), syndecan-4 (1C), spondin 2 (1D), fibroblast growth
factor 2 (FGF2;1 E ) ,a n dcollagen VI a1 (COL6A1;1 F ) ,
which are all involved in ECM regulation. The COL6A1
gene was also common between Experiments 1 and 2.
Versican and glypican-1 appeared to be expressed pre-
dominantly at the 18de stage when compared to later
stages in development. Interestingly, spondin 2 was
expressed almost exclusively at the 1d stage, during
muscle hypertrophy. Severald i f f e r e n c e sb e t w e e nt h e
RBC2 and F lines were observed by qPCR analysis that
were not detected with the significance threshold used
for the microarray analysis. Most notably, FGF2 expres-
s i o na tt h e1 8 d es t a g ew a st w i c ea sh i g hi nt h eR B C 2
line compared to that of the F line and nearly 3 times
greater at the 1d stage in the RBC2 line compared to
that of the F line.
Figure 2 shows results for genes involved in cell death/
apoptosis as determined by IPA: caspase-3 (2A), growth
arrest-specific 2 (GAS2;2 B ) ,death-associated protein
(DAP;2 C ) ,b-parvin (2D), platelet-derived growth factor
a (PDGFa;2 E ) ,nestin (2F), matrix g-carboxyglutamic
acid (GLA) protein (MGP;2 G ) ,a n dgelsolin (2H). The
gene b-parvin was also common to both Experiments 1
and 2. Caspase-3, GAS2, DAP,a n db-parvin all appeared
to be down-regulated as muscle develops. Nestin was
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times the expression of subsequent developmental stages.
The MGP gene, however, was expressed principally at
the 1d stage at 80.28 and 55.38 times the 18de expression
in RBC2 and F lines, respectively. Gelsolin expression
appeared to increase with muscle maturation and peak at
the 16wk time point.
Genes important to skeletal muscle growth and devel-
opment and calcium signaling are shown in Figure 3.
These are myostatin (3A), Activin IIB receptor (ActIIBR;
3B), calmodulin (3C), calreticulin (3D), and isotypes of
troponin: TNNC1 (3E), TNNI1 (3F), TNNT2 (3G), and
TNNT3 (3H). Myostatin expression dipped at 1d post-
hatch, when hypertrophy occurs in muscle; interestingly,
its expression was higher in the RBC2 line at 18de but
was higher in the F line by 16wk of development. In
conjunction, the myostatin receptor ActIIBR was highly
down-regulated at 16wk (18de expression was 18.69 and
10.95 times greater in RBC2 and F lines, respectively),
when myostatin expression is high. Relative calmodulin
and calreticulin expression tended to respond in oppo-
site directions with calmodulin expression highest at the
16wk stage and calreticulin highest at 18de and decreas-
ing as muscle matures. Of the troponins, TNNI1 and
TNNT2 exhibited similar profiles with predominant
expression at 18de that decreased substantially at the
other stages. Interestingly, TNNT3 expression appeared
to be regulated in the opposite direction of TNNT2.
The expression profiles of several other genes that
were common to both Experiments 1 and 2 but did not
Table 1 Primer information for genes selected for confirmation by qPCR
Gene GenBank
Accession #
Forward primer (5’®3’) Reverse primer (5’®3’) Amplicon
length,
bp
Tm,
°C
Activin IIB Receptor NM_204317 GAGGAGCGCATTGCTCAGAT GACAAGGCAGTCCGAGGTAGTG 60 83
Beta parvin XM_416459 CCAGTCCATACAACTCGCCTTT CTGTGGTAATACAGCTCACTGGATCT 71 77
BTB domain containing 11 XM_001234770 TCTCAAGATGCTGATTTCTGTTTGT GTATCGACACATCACTAGAGGAAAGATC 74 75
Calmodulin 1 NM_001110364 GGCTGGATACACTTGGTGCAT GGATCTGATGACCCAGGAAGTT 68 80
Calreticulin AY393845 CGCCCTGACAACACCTATGA CTCCAGGCTCCCCGATTC 63 82
Caspase 3 NM_204725 GGAACACGCCAGGAAACTTG TCTGCCACTCTGCGATTTACA 63 78
Collagen, type VI, alpha 1 (COL6A1) NM_205107 TTCCATTGGTGCTCTTGCTATG TTTGGGATGATGGCGATACC 79 78
Death-associated Protein (DAP) NM_001031003 TGGGCAGCTCTACTCTATGTGTTC CAAGAGCAGTTGTTTCTAACTCAAAAG 79 78
Fibroblast growth factor 2 (FGF2) NM_205433 CAATCAAAGGCGTAAGTGCAAA GCCAGCAATCTGCCATCCT 61 80
Gelsolin NM_204934 GCTTACCCCCCTCGTCTTTT TGAGTCAGATCTCCAGGGACTTC 80 80
Glypican-1 AY551002 CCAGAGGTGGAGGTGGACAT TCATGATCTTCAGCTGCATGATT 73 80
Growth Arrest-Specific 2 (GAS2) XM_420902 TGATCCTTTCTGTTCCTGACAAAG GGGAGAGGAAAAGGCAACCT 75 80
Hypoxanthine
phosphoribosyltransferase 1 (HPRT)
NM_204848 CACAAGAAGCAGCCAGTTACAGTATC CCCAGATTCCTTTTTACAGCAATAA 92 80
Matrix Gla protein (MGP) NM_205044 GCACAATGCGTGCTCTCATC AGCGGCCATGACCAAGAC 56 84
Met proto-oncogene NM_205212 CAACAATCTTCTCCACTTTCATTGG ATAGGGAGCAACACACTTCACGTT 83 77
Myostatin AF019625 CACCTGGTACACCAAGCAAATC TTGGTGGGTGTGCAGCAA 59 83
Nebulin-related anchoring protein
(NRAP)
XM_002194458 GGCGTACCTTCGGGAAATG GCAGAATTTCCGAAGCATCAG 122 82
Nestin NM_205033 GCCCCGCGACAATCG TGTTACAAACCAAAGGGAAATGG 71 83
5’-nucleotidase, cytosolic III (NT5C3) NM_204436 TGTGGAGTGGGAAAGTCATACTGTT CCTGTTGGTAAGAGGTTGAGAAACT 77 77
Plastin 3 NM_001006431 TGCTGAGGGCACAGCTACAC CAACTGAACCAAGATGCATACAAAA 67 78
Platelet-derived growth factor A
(PDGFA)
AB031021 TGCAACACCAGCAGTGTGAA TTTGCCACCTTGACACTTCTGT 65 81
Q3_Reed_1DPH_cDNA_08_B09_130
(Unknown)
EH286878 CCCTGTGCTCATCCTATAAAGCA CCACGATGCAGCAGGTGAT 61 82
Spondin 2 XM_420847 CGTTTTGTAGTTCTTCACCCTGCTA TCACATTCTGTTTCTTCTTCCAGACT 71 77
Syndecan-4 AY852251 GCCAACAGCAGCATCTTTGA CAACTGCTCCTCCTGCAATG 64 79
Troponin C type 1 (slow) (TNNC1) NM_205133 AGATGGACAGCCCGAATCTCT TGGGACCAAGGAGCTGATG 60 82
Troponin I type 1 (skeletal, slow)
(TNNI1)
XM_419242 TCTGCCCTCTTTGCACCATT GTTGTCCACGTGGTTCATCTCA 58 82
Troponin T type 2 (cardiac)(TNNT2) NM_205449 GGCTCAGCCATCAGATGCA CAGCAGAGCCCTGGCATAG 54 85
Troponin T type 3 (skeletal, fast)
(TNNT3)
NM_204922 CCCGTGCCTCAGTGATAACTAAA AGAAGAAAAGCAGCAGCAATAGC 68 78
Versican NM_204787 CAGGATCATTTGTTTGCGGTTA TCCTGATTCTTCCGCAAGTCA 60 80
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gene with unknown function, are shown in Figure 4.
These genes included: BTBD11 (4A), cMet (4B), plastin3
(4C), 5’-nucleotidase, cytosolic III (NT5C3; 4D), and neb-
ulin-related anchoring protein (NRAP; 4E). In addition, a
gene with no known annotation was chosen from the
top 40 genes differentially expressed by overall effect of
development (FDR < 1.0 × 10
-13)a n dw a ss u b s e q u e n t l y
coded Unknown (4F). Expression of these genes was
variable although line differences were observed at 1d
for all genes. Expression of NRAP was dramatically up-
r e g u l a t e da t1 da n d1 6 w kw h e nc o m p a r e dt o1 8 d e .
Expression profiles for these 28 genes confirmed that
microarray results were repeatable.
Discussion
Muscle growth and development from the embryonic to
the adult stage of an organism consists of a series of
exquisitely regulated and orchestrated changes in
expression of genes leading to muscle maturation.
Genetic selection for body weight and muscle mass is
ultimately based on differential expression of genes, and
this approach has resulted in dramatic improvements in
turkey growth rate, breast muscle mass, and feed effi-
ciency. However, selection for these performance traits
has inadvertently led to other undesirable traits includ-
ing myopathies [26,27], cardiomyopathies [28,29], skele-
tal deficiencies [11,30], and meat quality defects such as
Table 2 Breakdown of differentially expressed genes as
affected by skeletal muscle development (Experiment 1)
and by turkey genetic line (Experiment 2)
Experiment 1 Overall effect
FDR < 0.001 3474
RBC2 18de:1d 1d:16wk Total
Up 586 1066 1652
Down 463 429 892
Total 1049 1495
F 18de:1d 1d:16wk Total
Up 455 746 1201
Down 345 702 1047
Total 800 1448
Experiment 2 Overall effect
FDR < 0.10 16
18de RBC2:F
Up 39
Down 24
Total 63
1d RBC2:F
Up 5
Down 15
Total 20
16wk RBC2:F
Up 4
Down 4
Total 8
Table 3 Top five Networks, Functions, and Canonical Pathways from IPA analysis for Experiment 1 for RBC2 and F
lines
RBC2 F
Networks Tissue Development, Cellular Growth and Proliferation, Skeletal and
Muscular System Development and Function
Tissue Development, Skeletal and Muscular System
Development and Function, Tissue Morphology
Genetic Disorder, Skeletal and Muscular Disorders, Gene Expression Cellular Development, Cell Cycle, Gene Expression
Cancer, Cell Death, Cellular Assembly and Organization Cell Cycle, Infectious Disease, Inflammatory Disease
Gene Expression, Cellular Growth and Proliferation, Endocrine System
Development and Function
Cellular Development, Cellular Growth and Proliferation,
Respiratory System Development and Function
Cell-To-Cell Signaling and Interaction, Cellular Growth and
Proliferation, Cancer
Connective Tissue Development and Function, Organismal
Development, Skeletal and Muscular System Development and
Function
Functions Genetic Disorder Cancer
Skeletal and Muscular Disorders Skeletal and Muscular System Development and Function
Cardiovascular System Development and Function Tissue Morphology
Skeletal and Muscular System Development and Function Tissue Development
Tissue Development Small Molecule Biochemistry
Canonical
Pathways
Calcium Signaling Calcium Signaling
Hepatic Fibrosis/Hepatic Stellate Cell Activation Glycolysis/Gluconeogenesis
Methionine Metabolism Urea Cycle and Metabolism of Amino Groups
Pyruvate Metabolism Tight Junction Signaling
Tight Junction Signaling Arginine and Proline Metabolism
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Networks Cancer, Cell Morphology, Dermatological Diseases and Conditions
Cell Signaling, DNA Replication, Recombination, and Repair, Nucleic Acid Metabolism
Cell Cycle, Embryonic Development, Connective Tissue Development and Function
Cancer, Reproductive System Disease, Hematological Disease
Functions Cellular Assembly and Organization
Cancer
Cellular Movement
Cell Cycle
Renal and Urological Disease
Canonical Pathways PI3K/AKT Signaling
One Carbon Pool by Folate
N-Glycan Degradation
Biosynthesis of Steroids
Urea Cycle and Metabolism of Amino Groups
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Figure 1 Relative expression as determined by quantitative real-time RT-PCR of genes related to extracellular matrix (ECM) function.
Different letters (uppercase) represent differences between developmental stages for the RBC2 line; different letters (lowercase) represent
differences between developmental stages for the F line (P ≤ 0.05). * represents differences between the two genetic lines, RBC2 and F (P ≤
0.05); ^ represents differences between the two lines (0.05 < P < 0.10).
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associated decreased meat protein functionality [33].
The goals in the current study were to exploit the cap-
ability of a microarray approach to identify functional
pathways of genes and thus characterize molecular
events associated with muscle development and between
genetic lines of turkeys with different growth rates.
Obvious phenotypic differences exist between RBC2
birds and those from F or commercial lines. The F line
turkeys gain body weight faster and yield significantly
heavier breast muscles than the RBC2 birds [12]. In
addition, satellite cells from the F line have faster prolif-
eration and differentiation rates than those from the
RBC2 line [13]. Further, muscle damage with age is sig-
nificant between lines as birds from the F line display a
greater degree of muscle fiber fragmentation and areas
of hypercontraction compared to those of the RBC2
[26]. These phenotypic differences are likely the results
of differential gene expression throughout development.
This study identified over 3000 genes affected by
developmental stage (Experiment 1), but only 16 genes
were identified as being differentially expressed by over-
all effect of genetic line (Experiment 2). When consider-
ing effect of line within each developmental stage, the
highest number of differences occurred early in develop-
ment (18de stage). Expression changes in myogenic reg-
ulatory factor genes have previously been observed
between the F and RBC2 lines at the embryonic stage
[14], and satellite cells from F birds have been shown to
have increased proliferation rates relative to RBC2 birds
in vitro [13]. These results agree with the microarray
observations and suggest that phenotypic differences
between the two lines may largely be determined embry-
onically during myogenesis. It is possible that subtle dif-
ferences in gene expression observed in the current
study may be responsible for large phenotypic differ-
ences in body and breast muscle weight [12], breast
muscle morphology [26], and meat quality characteris-
tics [33] between the RBC2 and F lines at market age.
The Ingenuity Pathway Analysis (IPA) enabled the clus-
tering of differentially expressed genes into functional
categories, some of which were expected, while others
were novel. Expected differences provided biological vali-
dation of the microarray approach, while the novel differ-
ences provided new paths to pursue in furthering our
understanding of differences in turkey skeletal muscle
growth and development. Many genes that may act as
master regulators during development appeared in more
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Figure 2 Relative expression as determined by quantitative real-time RT-PCR of genes related to cell death/apoptosis. Different letters
(uppercase) represent differences between developmental stages for the RBC2 line; different letters (lowercase) represent differences between
developmental stages for the F line (P ≤ 0.05). * represents differences between the two genetic lines, RBC2 and F (P ≤ 0.05); ^ represents
differences between the two lines (0.05 < P < 0.10).
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Page 8 of 14than one Network, Function, or Canonical Pathway. The
identified gene expression differences were grouped by
function and discussed, highlighting several individual
genes of interest within each group.
Extracellular Matrix Genes
Previous studies have demonstrated that the ECM com-
prising the connective tissue surrounding muscle can
interact with growth factors, regulate cellular signal trans-
duction pathways, and affect growing and developing mus-
cle fibers [34-36]. Genes that fell into numerous functions
or canonical pathways as well as some genes that were not
included in IPA networks were selected for this group.
The ECM is composed mainly of collagens and non-
fibrous glycoproteins like proteoglycans. The expression of
three proteoglycans: versican, glypican-1, and syndecan-4,
was quantified in this study. Membrane-associated proteo-
glycans in the ECM are known to regulate numerous
growth factors, the major constituents that regulate activa-
tion, proliferation, and differentiation of satellite cells [8].
A predominant example is FGF2, a potent stimulator of
muscle fiber proliferation and a strong inhibitor of differ-
entiation [35,37]. This function would explain the high
FGF2 expression at 18de and 1d in the current study, as
these are periods of myoblast or satellite cell proliferation.
The interaction between FGF2 and the heparan sulfate
proteoglycans glypican-1 and syndecan-4 is required for
high-affinity binding of FGF2 to its cellular receptor [35].
Differences in expression of syndecan-4 have been
observed in vitro between developing RBC2 and F line
satellite cells [15], and RBC2 satellite cell expression of
syndecan-4 as well as glypican-1 were altered with the
addition of FGF2 [38]. Satellite cells from syndecan-4
knockout mice display defective patterns of activation,
proliferation, and differentiation [39], indicating a crucial
role in muscle development that is also supported for tur-
keys in the current study. In addition, syndecan-4 and
FGF2 appear to have similar expression profiles, especially
at 1d. Versican is a chondroitin sulfate proteoglycan that
was expressed predominantly at the 18de stage in this
study. Fernandez et al. (1991) hypothesized that this pro-
tein’s high embryonic expression at the time of fiber for-
mation may be involved in fiber spacing, establishing the
morphological structure of the muscle in chicks [40]. The
space between muscle fibers may play a critical role in the
water-holding capacity of mature muscle and may
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Figure 3 Relative expression as determined by quantitative real-time RT-PCR of genes related to calcium regulation/muscle function.
Different letters (uppercase) represent differences between developmental stages for the RBC2 line; different letters (lowercase) represent
differences between developmental stages for the F line (P ≤ 0.05). * represents differences between the two genetic lines, RBC2 and F (P ≤
0.05); ^ represents differences between the two lines (0.05 < P < 0.10).
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Page 9 of 14therefore be associated with quality defects like PSE meat.
It is therefore possible that characteristics that contribute
to meat quality are decided very early in myogenesis.
Dominant negative mutations in the COL6A1 gene,
the only collagen that was investigated in the current
study, are known to lead to Bethlem myopathy [41] and
Ulrich congenital muscle dystrophy [42]; COL6A1
knockout mice exhibit sarcolemmal disorganization [43].
Taken together, it is clear that expression of genes
whose proteins are located in the ECM of skeletal mus-
cle likely contribute significantly to myogenesis in RBC2
and F turkeys.
Cell Death/Apoptosis Genes
Cell death and apoptosis are necessary events in muscle
differentiation and maintenance. In addition, other
reports have shown similarities between mechanisms of
apoptosis and myoblast differentiation, suggesting that
similar pathways and effectors may be in use [44,45].
Therefore, it was logical to further evaluate the expres-
sion of several differentially expressed genes associated
with these functions. For example, caspase-3, an “execu-
tioner” cysteine protease in apoptosis [46], is necessary
for proper differentiation of C2C12 myoblasts [47].
However, several reports have shown that this role is
separate from apoptosis [44,45] although it employs
similar mechanisms, such as DNA strand breakage [48].
A component of the microfilament, GAS2, is a sub-
strate for caspase-3 and is involved in microfilament
reorganization, possibly an early event in apoptosis [49].
The protein is expressed in embryonic mouse limbs and
involved in apoptosis during interdigital development;
G A S 2m a ya l s ob ei n v o l v e di n myogenesis, possibly in
the fusion of myoblasts to form myotubules [50]. In
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Figure 4 Relative expression as determined by quantitative real-time RT-PCR of genes common to Experiments 1 and 2 and genes
without known functions. Unknown = Q3_Reed_1DPH_cDNA_08_B09_130. Different letters (uppercase) represent differences between
developmental stages for the RBC2 line; different letters (lowercase) represent differences between developmental stages for the F line (P ≤
0.05). * represents differences between the two genetic lines, RBC2 and F (P ≤ 0.05); ^ represents differences between the two lines (0.05 < P <
0.10).
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Page 10 of 14addition, GAS2 can regulate p53 action and apoptosis
through its inhibition of calpain [51]. Nestin is the initial
intermediate filament protein expressed during myogen-
esis [52-54], and phosphorylation of this protein is asso-
ciated with the disassembly of intermediate filaments
during mitosis [53]. Nestin is also associated with
increased survival of rat vascular smooth muscle cells
under stress [55]. Our results are in agreement as nestin
is expressed predominantly at the 18de stage in turkey
skeletal muscle when myoblasts are proliferating.
Another intriguing gene was DAP,w h i c hw a s
expressed most highly at the 18de stage and decreased
throughout development for both RBC2 and F birds.
The human homologue of the gene was first identified
in surviving HeLa cells treated with an antisense cDNA
library and the cytokine interferon-g to induce apoptosis
[56]. Very little is known about this gene other than it
seemed to be a candidate for positive mediators of cell
death [56,57] and that it may regulate autophagy in
injured planarians [58] and in amino acid-starved HeLa
cells [59]. In addition, DAP may play a role as a regula-
tor of turkey skeletal muscle proliferation and differen-
tiation as shown by our group’s recent work with
satellite cells in vitro (Vellemen et al., manuscript in
preparation).
Ca
2+ Signaling/Muscle Function Genes
The Ca
2+ ion acts as a second messenger in cell signal-
ing and in skeletal muscle contraction. Aberrant Ca
2+
signaling postmortem likely plays an important role in
the occurrence of meat quality defects that can lead to
significant economic losses in the pork and poultry
industries. During the postmortem conversion of muscle
to meat, increased Ca
2+ release from the sarcoplasmic
reticulum while the muscle temperature is still high is
thought to be responsible for skeletal muscle hyperme-
tabolism that accelerates pH decline, leading to protein
denaturation and loss of protein functionality [60,61]. A
point mutation in the “halothane gene” or ryanodine
receptor 1 (RYR1), the skeletal muscle sarcoplasmic reti-
culum Ca
2+ release channel, has been identified in the
pig [62] and has been associated with porcine stress syn-
drome (PSS), a sometimes fatal condition of malignant
hyperthermia that is triggered by stress and is a major
contributor to the development of PSE pork [60].
Genetic selection by pig breeders away from this muta-
tion has not fully resolved the PSE problem. However,
RYR1 became a logical candidate for examination in the
turkey, a species that has been similarly selected for
rapid lean muscle growth and also exhibits meat quality
defects such as PSE. Further investigation of this protein
in the turkey revealed a higher affinity for ryanodine in
heavier commercial turkeys than those from the RBC2
line [63], suggesting a higher open-state probability of
the Ca
2+ release channel. Multiple alternatively spliced
products were later discovered in the avian skeletal
muscle ryanodine receptor isoform, aRYR,i nR B C 2a n d
commercial turkeys [64], and these alternative splicing
sites are clustered in regions of the gene associated with
increased frequency of mutations [65]. Recently, alterna-
tive splicing and changes in aRYR expression have also
been implicated in the occurrence of PSE meat in broi-
ler chickens [66].
Several genes involved in Ca
2+ metabolism were iden-
tified as differentially expressed during development in
this study. Calreticulin functions as a Ca
2+ -binding cha-
perone and aids in maintaining Ca
2+ homeostasis in the
ER lumen of cells [67]. This protein also appears to be
mainly expressed early in murine cardiac development
and is essential for proper cardiac development [68].
Calmodulin is another Ca
2+ -binding protein that sensi-
tizes RYR1 to activation at nanomolar concentrations of
Ca
2+ and inhibits RYR1 at micromolar concentrations
[69]. However, more recent work suggests that calmodu-
lin is not an essential regulator of RYR1 [70]. Neverthe-
less, calmodulin plays a central role in calcium signal
transduction and the developmentally related changes in
gene expression suggest a key role for this protein.
Myostatin is a highly-conserved transforming growth
factor-b (TGF-b) family member that strongly inhibits
both hyperplasia and hypertrophy. Mutations or knockout
of the gene result in an extreme increase in skeletal muscle
mass in cattle and in mice [71]. In the current study, a dra-
matic decrease of myostatin expression was observed at 1d
post-hatch, which agrees with our understanding of myos-
tatin function as myofibers are rapidly undergoing hyper-
trophy at this stage. In addition, line differences at 18de
and 16wk were observed, with RBC2 birds expressing
myostatin significantly higher than F birds at 18de. This
result could imply that F birds are able to undergo a
higher degree of hyperplasia and actually produce more
mature muscle fibers, leading to greater muscle mass. At
16wk, F-line birds expressed significantly more myostatin,
suggesting that the faster growth rate of the heavier birds
plateaus sooner than the slower-growing RBC2-line birds.
Activin receptor type IIB (ActIIBR) functions as a serine/
threonine kinase receptor for myostatin as well as other
TGF- b family members, and binding of these ligands to
ActIIBR activates the Smad signal transduction pathway to
regulate gene expression [72]. Inhibition of myostatin
activity by construction of a dominant-negative ActRIIB
lacking a kinase domain resulted in increased muscle
hyperplasia and hypertrophy in mice, as well as competi-
tion with the TGF-b family member follistatin [71]. Treat-
ment of chicken fetal myoblasts with myostatin altered
expression of genes involved in myogenic differentiation,
cell architecture, energy metabolism, signal transduction
and apoptosis [73], suggesting that increased myostatin
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changes.
Troponins are key proteins that are regulated by
changes in intracellular Ca
2+ concentrations and are
responsible for striated muscle contraction. The three
subunits of troponin interact with each other to bind
Ca
2+ (TNNC), inhibit myosin ATPase activity (TNNI),
and to bind tropomyosin (TNNT) [74]. Transcript abun-
dance of the fast/skeletalm u s c l ei s o f o r mo fT N N T ,
TNNT3, increased with development in the current
study, peaking at 16wk. Interestingly, the cardiac iso-
form, TNNT2, was chiefly expressed in the embryonic
skeletal muscle, and its expression decreased during ske-
letal muscle development, which is consistent with pre-
vious findings in chicken [75,76]. Expression of another
slow-twitch muscle/cardiac isoform of troponin, TNNI1,
followed this pattern as well. The expression of all of
the troponin isoforms is also in agreement with what is
k n o w na b o u tm y o f i b r i l l a rp r o t e i ne x p r e s s i o ni nr a ts k e -
letal muscle, as slow/cardiac forms are expressed during
the development of myofibrils with a switch to fast/ske-
letal forms during postnatal growth and muscle regen-
eration [77]. These genes involved in muscle growth and
Ca
2+ signaling may be valuable candidates for changes
observed in turkey skeletal muscle development.
Miscellaneous/Genes of Unknown Function
One of the goals of the current study was to identify
novel genes with unknown or uncertain functions that
may play important roles in skeletal muscle develop-
ment. These genes may play important roles in myogen-
esis and development even though their annotations and
functions have yet to be defined or may not have clear
roles in skeletal muscle. In the current study, one gene
without known annotation but identified as very highly
differentially expressed by microarray analysis was cho-
sen for further confirmation by qPCR along with others
that did not easily fit into a functional category. These
genes all showed line differences at 1d, indicating a pos-
sible important role during muscle hypertrophy that
may help explain phenotypic differences between the
slow-growing randombred line and the line selected for
increased 16-wk body weight.
Several genes identified in this study were first discov-
ered and their activities characterized in tissue types
other than skeletal muscle. For example, spondin 2, (also
known as mindin), which fell into the ECM group in
our study, is expressed in spleen, lymph nodes, and den-
dritic cells and may be crucial to immune function [78].
In the current study, spondin 2 was expressed at highest
levels at 1d post-hatch, over 11 times higher than its
18de expression in both turkey lines. The MGP gene
was first cloned in chickens and found in highest levels
in bones and relatively low levels in skeletal muscle [79].
Previous studies indicate its role in the inhibition of vas-
cular calcification, as MGP knockout mice die within 2
months due to blood vessel rupture [80]. It may also be
important in intracellular calcium homeostasis [81].
While MGP was grouped into the “Cell Death” function
by the IPA software, its association with apoptosis is not
clear [81]. It was another gene that appeared to be
“turned on” at 1d post-hatch, with 80.28 and 55.38
times the 18de expression in RBC2 and F lines, respec-
tively. Thus, this study has begun to uncover novel roles
of these genes, which have been characterized in other
tissues, in muscle growth and development.
Other interesting findings include the variation in the
timing and extent of expression during development. A
few stand-out genes were highly expressed at only one
stage of development, clearly turned on or off in what
appears to be carefully choreographed regulation. Dur-
ing the embryonic stage, when muscle cell hyperplasia is
occurring, versican, glypican-1, betaparvin, nestin,
TNNI1,a n dTNNT2 were expressed at least 5 times,
and in the case of nestin greater than 100 times, higher
than later developmental stages. Spondin 2 and MGP
were both highly expressed at 1d posthatch with very
little expression at 18de or 16wk. The NT5C3 and
TNNT3 genes peaked at 16wk of development.
Conclusions
Taken together, results from the current study demon-
strated obvious differences in gene expression between
three key developmental stages of turkey skeletal muscle
growth. Although differences between the two genetic
lines may be more subtle, the TSKMLO microarray plat-
form proved useful in identifying candidate genes
responsible for differences in muscle growth and opened
the door for future experiments that focus on these can-
didate genes, their proteins, and their functions in tur-
key skeletal muscle.
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